Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00001663
Other study ID # 970053
Secondary ID 97-N-0053
Status Completed
Phase Phase 1
First received November 3, 1999
Last updated March 3, 2008
Start date January 1997
Est. completion date January 2002

Study information

Verified date January 2002
Source National Institutes of Health Clinical Center (CC)
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Interventional

Clinical Trial Summary

Myoclonus is a condition related to epilepsy of involuntary twitching or jerking of the limbs.

The purpose of this study is to determine if stimulation of the brain with magnetic pulses can decrease myoclonus. Researchers believe that this may be possible because in studies on normal volunteers, magnetic stimulation made areas of the brain difficult to activate for several minutes. In addition, early studies on patients with myoclonus have shown magnetic stimulation to be effective at decreasing involuntary movements.

Transcranial Magnetic Stimulation (TMS) is a non-invasive technique that can be used to stimulate brain activity and gather information about brain function. It is very useful when studying the areas of the brain and spinal cord related to motor activity (motor cortex and corticospinal tract). Repetitive transcranial magnetic stimulation (rTMS) involves the placement of coil of wire (electromagnet) on the patient's scalp and rapidly turning on and off the electrical current. The changing magnetic field produces weak electrical currents in the brain near the coil. This permits non-invasive, relatively localized stimulation of the surface of the brain (cerebral cortex). The effect of magnetic stimulation varies, depending upon the location, intensity and frequency of the magnetic pulses.

Researchers plan to use rTMS for 10 days on patients participating in the study. The 10 day period will be broken into 5 days of active repetitive magnetic stimulation and 5 days of placebo "ineffective" stimulation. At the end of the 10 day period, if the results show that rTMS was beneficial, patients may undergo an additional 5 days of active rTMS.


Description:

Repetitive transcranial magnetic stimulation (rTMS) at frequencies in the single Hz range causes a decrease in the excitability of the primary motor cortex and there is preliminary evidence that it can suppress abnormal excess cortical activity. We plan to test 1 Hz rTMS as treatment for cortical myoclonus.


Recruitment information / eligibility

Status Completed
Enrollment 10
Est. completion date January 2002
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Age 5 to 90 with severe cortical myoclonus.

No intracranial metal hardware (excluding dental fillings), pacemakers, indwelling medication pumps, cochlear implants, intracardiac lines, significant intracranial masses or increased intracranial pressure.

Subject must not be pregnant.

Study Design

Endpoint Classification: Safety Study, Primary Purpose: Treatment


Intervention

Device:
Magstim Super Rapid Stimulator


Locations

Country Name City State
United States National Institute of Neurological Disorders and Stroke (NINDS) Bethesda Maryland

Sponsors (1)

Lead Sponsor Collaborator
National Institute of Neurological Disorders and Stroke (NINDS)

Country where clinical trial is conducted

United States, 

References & Publications (3)

Cantello R, Gianelli M, Civardi C, Mutani R. Magnetic brain stimulation: the silent period after the motor evoked potential. Neurology. 1992 Oct;42(10):1951-9. — View Citation

Fuhr P, Agostino R, Hallett M. Spinal motor neuron excitability during the silent period after cortical stimulation. Electroencephalogr Clin Neurophysiol. 1991 Aug;81(4):257-62. — View Citation

Inghilleri M, Berardelli A, Cruccu G, Manfredi M. Silent period evoked by transcranial stimulation of the human cortex and cervicomedullary junction. J Physiol. 1993 Jul;466:521-34. — View Citation

See also
  Status Clinical Trial Phase
Recruiting NCT00018889 - Phenotype/Genotype Correlations in Movement Disorders
Completed NCT02160886 - Effects of a Task Oriented Intervention With Two Goal-setting Approaches N/A
Completed NCT00001549 - Diagnosis and Natural History Study of Patients With Neurological Conditions N/A
Completed NCT00001361 - Magnetic Resonance Imaging Studies of Motor and Thought Processes N/A
Recruiting NCT05413291 - Natural History Protocol for Movement Disorders
Completed NCT02938754 - Rehabilitation Gaming System for Cerebral Palsy N/A
Completed NCT02699398 - Domiciliary VR Rehabilitation N/A
Recruiting NCT00331669 - Efficacy and Safety of Deep Brain Stimulation (DBS) of the Pallidal (GPi) in Patients With Tardive Dystonia Phase 2
Completed NCT00105131 - Genetic Characterization of Parkinson's Disease N/A
Completed NCT00001324 - PET Scan to Study Brain Control of Human Movement
Recruiting NCT00001252 - Human Movement Database
Completed NCT00610233 - Effect of Deep Brain Stimulation on Lower Urinary Tract Function N/A
Completed NCT00017979 - Study of Brain Control of Movement N/A
Completed NCT00017966 - Brain Excitability During Self-Paced Voluntary Movements N/A
Completed NCT00118586 - Neuropathology of Spasmodic Dysphonia
Recruiting NCT02014246 - Genetic Characterization of Movement Disorders and Dementias
Completed NCT00001780 - Magnetic Stimulation of the Human Nervous System N/A
Recruiting NCT02588638 - Next Generation Sequencing Diagnostics - On the Road to Rapid Diagnostics for Rare Diseases
Completed NCT01037361 - Cerebral Activity Related to Primary Motor Stereotypies in Children: An EEG Study.
Completed NCT02689466 - Cholinergic Receptor Imaging in Dystonia